• Eli Lilly Shows Off More Verzenio Data at AACR biospace
    April 19, 2018
    Eli Lilly  unveiled final data from the MONARCH 3 trial that won the latest nod from the U.S. Food and Drug Administration for the treatment of some breast cancer patients.
PharmaSources Customer Service